PHOTO
Ajman : The Sheikh Khalifa Medical City-Ajman (SKMCA) Lab has been awarded the College of American Pathologists (CAP) accreditation as a result of the successful site inspection; a part of the CAP’s Accreditation Programs.
The College of American Pathologists (CAP) is one of the world’s largest organizations of board-certified pathologists, promoting excellence in laboratories and advancing the practice of pathology and laboratory science.
The 70-year-old organization’s goal is to improve patient safety by advancing the quality of pathology and laboratory services through education, standard setting and ensuring laboratories meet or exceed regulatory requirements.
“The process of obtaining the accreditation confirms that our management, quality, and technical systems are in line with the highest possible standards. We provide accuracy and reliability coupled with appropriate administrative procedures to guarantee that all steps starting with the sample, the analysis and the reporting are unified, measured, and monitored,” Acting CEO Mr Magnus Ericsson, asserted.
“Pure Health Group, endeavors to provide best patient care through its governance of healthcare institutions like SKMCA. Achieving such accreditation during COVID-19 reflects on the commitment to maintain quality standards even during the pandemic. It also assures our patients the reliability, accuracy, and timeliness of their test results, leading to accurate patient diagnosis through following best practices and international standards,” explained Allan Boston, The Medical Office CEO at Pure Health Group.
-Ends-
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
